Ethris

Ethris is a biotech company in Munich, Germany, founded in 2009. It has raised $69.3M across 4 rounds, most recently a Grant in 2025 (est.).

Paving a new path from genes to therapeutic proteins

Headquarters
Munich, Bavaria
Employees
11–50
Founded
2009
Business Model
B2B
Website
ethris.com
Total Funding
$69.3M
Last Round
GrantJan 2025
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 3 investors for this company. The full record is or through the API.

About

Ethris GmbH is a clinical-stage biotechnology company based in Planegg near Munich, Germany, pioneering next-generation messenger RNA (mRNA) therapeutics and vaccines for severe respiratory diseases. Founded by Dr. Carsten Rudolph and Prof. Dr. Christian Plank, Ethris developed its proprietary SNIM® RNA and SNaP LNP® delivery platforms, which enable multi-route administration of mRNA including differentiated inhaled delivery directly to the lungs—a key differentiator for treating conditions such as asthma and COPD. The company has entered strategic collaborations with major partners including AstraZeneca and MedImmune to advance its mRNA programs, and its lead asset ETH47 targets the prevention of asthma exacerbations.

Summary

It lists 11–50 employees. It has raised $69.3M in total across 4 rounds, most recently a Grant round in 2025 (est.). Investors include Cipla, Laureus Capital and OrbiMed.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Grant2025 (est.)

Sign up to see all 4 events

Funding: Series A through Corporate Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ethris on Indexed.vc
<a href="https://indexed.vc/companies/ethris"><img src="https://indexed.vc/api/badge/company/ethris" alt="Ethris on Indexed.vc" width="260" height="76" /></a>